FDA Revokes Approval Of Avastin For Treatment Of Breast Cancer

November 22nd, 2011 | Wrongful death

The Food and Drug Administration (FDA) Commissioner, Margaret Hamburg, announced last Friday that the agency has revoked its approval of the drug Avastin for treatment of breast cancer patients. Read More